This paper is in the following e-collection/theme issue:

Patient-Reported Outcome Measures (PROMs) (275) Chemotherapy and Side Effects Management (52) Skin Cancer and Melanoma Prevention (110)

Published on in Vol 22, No 4 (2020): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14896, first published .
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences

Authors of this article:

Lærke K Tolstrup1, 2 Author Orcid Image ;   Helle Pappot3 Author Orcid Image ;   Lars Bastholt1, 2 Author Orcid Image ;   Ann-Dorthe Zwisler1, 4 Author Orcid Image ;   Karin B Dieperink1, 2 Author Orcid Image
Article Authors Cited by (22) Tweetations (15) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.